Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946

Sort by:

Enoyl [Acyl Carrier Protein] Reductase [NADH] FabI (NADH Dependent Enoyl ACP Reductase or Enoyl ACP Reductase or EC 1.3.1.9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Enoyl [Acyl Carrier Protein] Reductase [NADH] FabI (NADH Dependent Enoyl ACP Reductase or Enoyl ACP Reductase or EC 1.3.1.9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Mo...

May 2022 48 pages

Enoyl [Acyl Carrier Protein] Reductase [NADH] (FAS-II Enoyl ACP Reductase or NADH Dependent 2-Trans-Enoyl ACP Reductase or inhA or EC 1.3.1.9) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Enoyl [Acyl Carrier Protein] Reductase [NADH] (FAS-II Enoyl ACP Reductase or NADH Dependent 2-Trans-Enoyl ACP Reductase or inhA or EC 1.3.1.9) Drugs in Development by Therapy Areas and Indications, St...

May 2022 35 pages

Enteritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Enteritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Enteritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 43 pages

Enterobacteriaceae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Enterobacteriaceae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Enterobacteriaceae Infections Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 226 pages

Enterococcus Faecium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Enterococcus Faecium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Enterococcus Faecium Infections Drugs in Development by Stages, Target, MoA, RoA...

May 2022 84 pages

Enterococcus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Enterococcus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Enterococcus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 99 pages

Enterovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Enterovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Enterovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 143 pages

Envelope Protein M (Matrix Protein) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Envelope Protein M (Matrix Protein) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Envelope Protein M (Matrix Protein) Drugs in Developm...

May 2022 36 pages

Ependymoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ependymoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ependymoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 56 pages

Ephrin Type A Receptor 2 (Epithelial Cell Kinase or Tyrosine Protein Kinase Receptor ECK or EPHA2 or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ephrin Type A Receptor 2 (Epithelial Cell Kinase or Tyrosine Protein Kinase Receptor ECK or EPHA2 or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...

May 2022 43 pages

Epidermal Growth Factor (EGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Epidermal Growth Factor (EGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Epidermal Growth Factor (EGF) Drugs in Development by Thera...

May 2022 44 pages

Epileptic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Epileptic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Epileptic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 48 pages

Epithelial Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Epithelial Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Epithelial Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 248 pages

Epithelial Sodium Channel (ENaC or SCNN1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Epithelial Sodium Channel (ENaC or SCNN1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Epithelial Sodium Channel (ENaC or SCNN1) Drugs...

May 2022 42 pages

Esophageal Squamous Cell Carcinoma (ESCC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Esophageal Squamous Cell Carcinoma (ESCC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Esophageal Squamous Cell Carcinoma (ESCC) Drugs in Development by Stag...

May 2022 126 pages

Essential Tremor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Essential Tremor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Essential Tremor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 48 pages

Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule T...

May 2022 59 pages

Eukaryotic Translation Initiation Factor 4E (eIF 4F 25 kDa Subunit or mRNA Cap Binding Protein or EIF4E) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Eukaryotic Translation Initiation Factor 4E (eIF 4F 25 kDa Subunit or mRNA Cap Binding Protein or EIF4E) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 36 pages

Excitatory Amino Acid Transporter 2 (Glutamate-Aspartate Transporter II or Sodium Dependent Glutamate-Aspartate Transporter 2 or Solute Carrier Family 1 Member 2 or SLC1A2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Excitatory Amino Acid Transporter 2 (Glutamate-Aspartate Transporter II or Sodium Dependent Glutamate-Aspartate Transporter 2 or Solute Carrier Family 1 Member 2 or SLC1A2) Drugs in Development by The...

May 2022 35 pages

Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Exo Alpha Siali...

May 2022 49 pages

Exocrine Pancreatic Insufficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Exocrine Pancreatic Insufficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Exocrine Pancreatic Insufficiency Drugs in Development by Stages, Target, MoA,...

May 2022 36 pages

Extrahepatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Extrahepatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Extrahepatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 51 pages

Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Extranodal Margina...

May 2022 66 pages

Facioscapulohumeral Muscular Dystrophy (FSHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Facioscapulohumeral Muscular Dystrophy (FSHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Facioscapulohumeral Muscular Dystrophy (FSHD) Drugs in Development...

May 2022 48 pages

Familial Amyloid Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Familial Amyloid Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Familial Amyloid Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA...

May 2022 37 pages

Familial Chylomicronemia (Type I Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Familial Chylomicronemia (Type I Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Familial Chylomicronemia (Type I Hyperlipoproteinemia) Dr...

May 2022 35 pages

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Familial Hypercholesterolemia (Type II Hyperlipopro...

May 2022 63 pages

Fatty Acid Amide Hydrolase (Oleamide Hydrolase 1 or Anandamide Amidohydrolase or FAAH or EC 3.5.1.99) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Fatty Acid Amide Hydrolase (Oleamide Hydrolase 1 or Anandamide Amidohydrolase or FAAH or EC 3.5.1.99) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Pla...

May 2022 48 pages

Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 184 pages

Fc Fragment Of IgG Low Affinity III Receptor (CD16 or FCGR3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Fc Fragment Of IgG Low Affinity III Receptor (CD16 or FCGR3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Fc Fragment Of IgG Low Affin...

May 2022 64 pages

Febrile Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Febrile Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Febrile Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 47 pages

Fecal Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Fecal Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fecal Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 37 pages

Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview...

May 2022 41 pages

Fibrinogen (Coagulation Factor I or FG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Fibrinogen (Coagulation Factor I or FG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Fibrinogen (Coagulation Factor I or FG) Drugs in...

May 2022 43 pages

Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Mol...

May 2022 79 pages

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molec...

May 2022 83 pages

Fibroblast Growth Factor Receptor (FGFR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Fibroblast Growth Factor Receptor (FGFR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Fibroblast Growth Factor Receptor...

May 2022 157 pages

Fibronectin (Cold Insoluble Globulin or FN1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Fibronectin (Cold Insoluble Globulin or FN1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Fibronectin (Cold Insoluble Globulin or FN1)...

May 2022 36 pages

Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...

May 2022 214 pages

Flavivirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Flavivirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Flavivirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 277 pages

Focal Adhesion Kinase (FAK or EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Focal Adhesion Kinase (FAK or EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Focal Adhesion Kinase (FAK or EC 2.7.10.2) Dru...

May 2022 48 pages

Focal Segmental Glomerulosclerosis (FSGS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Focal Segmental Glomerulosclerosis (FSGS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Focal Segmental Glomerulosclerosis (FSGS) Drugs in Development by Stag...

May 2022 66 pages

Follicle Stimulating Hormone Receptor (Follitropin Receptor or FSHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Follicle Stimulating Hormone Receptor (Follitropin Receptor or FSHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Follicle Stimulating...

May 2022 59 pages

Follicular Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Follicular Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Follicular Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 323 pages

Follicular Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Follicular Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Follicular Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 52 pages

Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 99 pages

Forkhead Box Protein P3 (Scurfin or FOXP3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Forkhead Box Protein P3 (Scurfin or FOXP3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Forkhead Box Protein P3 (Scurfin or FOXP3) Dru...

May 2022 39 pages

Fuchs Endothelial Corneal Dystrophy (FECD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Fuchs Endothelial Corneal Dystrophy (FECD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fuchs Endothelial Corneal Dystrophy (FECD) Drugs in Development by St...

May 2022 41 pages

Fungal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Fungal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fungal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 243 pages

Fungal Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Fungal Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fungal Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 36 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...